36 Healthcare Stocks Moving In Monday's After-Market Session

Gainers

• NantHealth, Inc. NH stock increased by 67.2% to $2.19 during Monday's after-market session.

• Acceleron Pharma, Inc. XLRN stock rose 66.3% to $87.90. The most recent rating by Citigroup, on January 22, is at Buy, with a price target of $75.00.

• Surface Oncology, Inc. SURF shares moved upwards by 17.2% to $3.40.

• Cleveland BioLabs, Inc. CBLI stock rose 14.9% to $4.71.

• Inovio Pharmaceuticals, Inc. INO shares increased by 11.7% to $5.94. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

• Vaccinex, Inc. VCNX shares rose 10.9% to $7.80.

• China SXT Pharmaceuticals, Inc. SXTC shares rose 9.9% to $1.22.

• Lianluo Smart, Inc. LLIT shares increased by 9.1% to $3.00.

• Cocrystal Pharma, Inc. COCP shares rose 8.4% to $0.89.

• Miragen Therapeutics, Inc. MGEN stock moved upwards by 7.5% to $1.57. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.

• BioCryst Pharmaceuticals, Inc. BCRX shares surged 7.5% to $3.45. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.

• Harvard Bioscience, Inc. HBIO stock surged 6.8% to $3.30.

• Moderna, Inc. MRNA stock rose 6.6% to $24.25. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.

• Kitov Pharma, Inc. KTOV shares moved upwards by 6.5% to $0.76.

• Applied Genetic Tech, Inc. AGTC shares increased by 5.6% to $8.30.

• Vir Biotechnology, Inc. VIR shares rose 5.3% to $26.10. The most recent rating by Baird, on November 14, is at Neutral, with a price target of $17.00.

• NuCana, Inc. NCNA stock rose 5.3% to $5.56. The most recent rating by H.C. Wainwright, on November 15, is at Buy, with a price target of $17.00.

• Akorn, Inc. AKRX stock increased by 4.5% to $1.40.

• Pulmatrix, Inc. PULM shares surged 4.3% to $1.70.

• GlycoMimetics, Inc. GLYC shares moved upwards by 4.0% to $4.45. The most recent rating by Roth Capital, on November 14, is at Buy, with a price target of $12.00.

• Unum Therapeutics, Inc. UMRX stock surged 3.9% to $0.98. The most recent rating by Morgan Stanley, on November 27, is at Overweight, with a price target of $3.00.

• Neovasc, Inc. NVCN stock surged 3.8% to $3.27.

• Conformis, Inc. CFMS shares moved upwards by 3.7% to $1.12.

• Aethlon Medical, Inc. AEMD stock moved upwards by 3.5% to $4.11.

• Aevi Genomic Medicine, Inc. GNMX stock surged 3.5% to $0.19.

• Owens & Minor, Inc. OMI shares increased by 3.5% to $6.80. The most recent rating by Baird, on January 21, is at Outperform, with a price target of $9.00.

• Therapix Biosciences, Inc. TRPX stock surged 3.5% to $0.57.

• CASI Pharmaceuticals, Inc. CASI stock rose 3.4% to $3.05.

• NeuroMetrix, Inc. NURO stock rose 3.1% to $3.63.

Losers

• NeoGenomics, Inc. NEO shares plummeted 4.9% to $31.10 during Monday's after-market session. The most recent rating by First Analysis, on January 23, is at Outperform, with a price target of $35.00.

• Immunogen, Inc. IMGN stock decreased by 4.2% to $4.37.

• ChemoCentryx, Inc. CCXI shares plummeted 4.0% to $39.00. The most recent rating by H.C. Wainwright, on January 24, is at Buy, with a price target of $60.00.

• Syros Pharmaceuticals, Inc. SYRS stock declined 3.9% to $6.98. The most recent rating by Wedbush, on January 17, is at Neutral, with a price target of $9.00.

• Endo International, Inc. ENDP shares fell 3.8% to $5.60. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $7.00.

• Tocagen, Inc. TOCA stock declined 3.6% to $0.52.

• Durect, Inc. DRRX stock fell 3.3% to $1.91. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.